Table 2

Percentage of Caco-2 cells of monolayers with normal microtubules

TreatmentNormal
%
Vehicle99  ± 1
2.5% EtOH72  ± 22-a
15% EtOH27  ± 52-a
l-NIL alone97  ± 4
l-NIL + 2.5% EtOH84  ± 22-b
l-NIL + 15% EtOH70  ± 42-b
Urate + 2.5% EtOH82  ± 62-b
Urate + 15% EtOH73  ± 72-b
l-Cysteine + 2.5% EtOH86  ± 32-b
l-Cysteine + 15% EtOH69  ± 52-b
d-Cysteine alone96  ± 2
d-Cysteine + 2.5% EtOH71  ± 32-c
d-Cysteine + 15% EtOH22  ± 42-c
SOD + 2.5% EtOH85  ± 22-b
SOD + 15% EtOH70  ± 52-b
iSOD alone94  ± 3
iSOD + 2.5% EtOH65  ± 52-c
iSOD + 15% EtOH24  ± 62-c

Values are mean ± S.E. after treatments. Monolayers were exposed to EtOH for 30 min or were preincubated with 1) a selective iNOS inhibitor [l-NIL (1 mM)] or 2) ONOO scavengers urate (0.5 mM) or l-cysteine (3 mM and, as control,d-cysteine) or SOD 300 U/ml and the heat-inactivated iSOD) for 30 min (except 1 h for l-NIL studies) before the exposure to EtOH. Controls were incubated in isotonic saline/vehicle. From 100 to 150 cells from monolayers per slide (well) were examined by high-resolution laser confocal and the percentage of cells displaying normal microtubule cytoskeleton was determined. n = 6 per group.

  • 2-aP < .05 compared with the vehicle (control), l-NIL,l-cysteine, SOD, or urate pretreatment.

  • 2-bP < .05 compared with the EtOH alone, d-cysteine, or iSOD pretreatment.

  • 2-cP < .05 compared with corresponding l-cysteine (or SOD) + EtOH.